MOLECULAR PATHOGENESIS OF HYPOPHOSPHATEMIC RICKETS
MOLECULAR PATHOGENESIS OF HYPOPHOSPHATEMIC RICKETS
批准号:
7317318
负责人:
SUZANNE M JAN DE BEUR
金额:
$33.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-06-30
关键词:
ActinsBindingCell LineCell physiologyComplexCytoskeletonDataDevelopmentDiseaseDisruptionEnergy TransferFamilial hypophosphatemic bone diseaseFamilyFibroblast Growth FactorFibroblast Growth Factor ReceptorsFunctional disorderGoalsHomeostasisHormonalHormone ResponsiveInheritedInorganic Phosphate TransporterInvestigationKidneyKidney DiseasesKnowledgeLeadMacromolecular ComplexesMediatingMembraneMetabolismMolecularMultiprotein ComplexesOsteomalaciaPathogenesisPhosphorylationPhysiologicalPlayProcessProtein BindingProteinsProtonsProximal Kidney TubulesPublishingReceptor SignalingRegulationRoleSignal PathwaySignal TransductionSignaling MoleculeSkeletal systemSmall Interfering RNASodiumTubular formationbaseinhibitor/antagonistinorganic phosphateinsightmembermineralizationnovel therapeuticsresearch studyscaffoldtherapeutic targettraffickingtumor
中文摘要
描述(由申请人提供):通过对获得性和遗传性低磷血症的研究,对磷酸盐稳态的激素调节机制有了新的认识。FGF-23在多种形式的低磷血症佝偻病的病理生理中起核心作用,包括肿瘤诱导的骨软化症(TIO)、x连锁低磷血症佝偻病(XLH)和常染色体显性低磷血症佝偻病(ADHR)。然而,这种有效的近端肾小管磷酸盐运输抑制剂调节主要激素反应性钠依赖性磷酸盐转运蛋白(NaPi-lla)的机制实际上尚未被探索。我们假设FGF-23通过激活FGF受体促进NaPi-lla的内化,从而抑制钠依赖性磷酸盐运输。此外,内化是通过在与肌动蛋白细胞骨架相互作用的钠氢离子交换相关因子-1 (NHERF-1)支架上组装包含napi - la和信号分子的大分子复合物来完成的。在Specific Aim 1中,我们将确定FGF-23是否通过已知的fgfr促进NaPi-lla内化。我们将进一步确定导致麻醉品贩运的主要信号通路。在Specific Aim 2中,我们将研究NHERF-1在FGF-23介导的NaPi-lla内化中的作用。在Specific Aim 3中,我们将确定NHERF-1结合伙伴,用于整合FGF-23信号和NaPi-lla内化。本提案中概述的实验将建立FGF-23调节近端肾小管中磷酸盐处理的机制,包括控制NaPi-lla运输,激活细胞信号通路以及整合信号和NaPi-lla膜定位的NHERF-1依赖性多蛋白复合物的组装。更好地了解FGF-23信号及其对肾脏磷酸盐处理和最终骨骼矿化的影响将为磷酸盐稳态紊乱提供新的治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Through the study of acquired and inherited hypophosphatemic disorders a new understanding of the hormonal regulators of phosphate homeostasis is emerging. FGF-23 plays a central role in the pathophysiology of several forms of hypophosphatemic rickets including tumor-induced osteomalacia (TIO), X-linked hypophosphatemic rickets (XLH) and autsomal dominant hypophosphatemic rickets (ADHR). However, the mechanism of by which this potent inhibitor of proximal renal tubular phosphate transport modulates the main hormone-responsive sodium-dependent phosphate transporter (NaPi-lla) is virtually unexplored. We hypothesize that FGF-23 inhibits sodium-dependent phosphate transport by promoting internalization of NaPi-lla via activation of FGF receptors. Furthermore, internalization is accomplished by the assembly of a macromolecular complex involving NaPi-lla and signaling molecules on the scaffold of Sodium hydrogen ion exchanger related factor-1 (NHERF-1) that interacts with the actin cytoskeleton. In Specific Aim 1, we will determine if FGF-23 acts via known FGFRs to promote NaPi-lla internalization. We will further define the major signaling pathway(s) responsible for NaPi-lla trafficking. In Specific Aim 2, we will examine role of NHERF-1 in FGF-23 mediated internalization of NaPi-lla. In Specific Aim 3, we will identify NHERF-1 binding partners which serve to integrate FGF-23 signaling and NaPi-lla internalization. The experiments outlined in this proposal will establish the mechanism by which FGF-23 regulates phosphate handling in the proximal renal tubule including control of NaPi-lla trafficking, activation of the cell signaling pathways and the assembly of NHERF-1 dependent multiprotein complexes that integrate signaling and NaPi-lla membrane localization. A better understanding of FGF-23 signaling and its consequences for renal phosphate handling and ultimately skeletal mineralization will provide new therapeutic targets for disorders of phosphate homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR PATHOGENESIS OF HYPOPHOSPHATEMIC RICKETS
-
批准号:7436318
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2007
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
MOLECULAR PATHOGENESIS OF HYPOPHOSPHATEMIC RICKETS
-
批准号:7655547
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2007
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
MOLECULAR PATHOGENESIS OF HYPOPHOSPHATEMIC RICKETS
-
批准号:7783360
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
MOLECULAR PATHOGENESIS OF HYPOPHOSPHATEMIC RICKETS
-
批准号:8143407
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2007
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
ENDOCRINE REGULATORS OF NORMAL PHOSPHATE HOMEOSTASIS
-
批准号:7375828
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2005
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
ENDOCRINE REGULATORS OF NORMAL PHOSPHATE HOMEOSTASIS
-
批准号:7204463
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2004
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
Role of FGF-23 in Regulation of Phosphate Homeostasis
-
批准号:6679731
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2003
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
Role of FGF-23 in Regulation of Phosphate Homeostasis
-
批准号:6801028
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2003
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
PHOSPHOTONIN--A NOVEL PHOSPHATE REGULATORY HORMONE
-
批准号:6516728
-
项目类别:
-
资助金额:$13.11万
-
财政年份:1999
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
PHOSPHOTONIN--A NOVEL PHOSPHATE REGULATORY HORMONE
-
批准号:6176007
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1999
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
PHOSPHOTONIN--A NOVEL PHOSPHATE REGULATORY HORMONE
-
批准号:6380106
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1999
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
PHOSPHOTONIN--A NOVEL PHOSPHATE REGULATORY HORMONE
-
批准号:6634731
-
项目类别:
-
资助金额:$13.16万
-
财政年份:1999
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
PHOSPHOTONIN--A NOVEL PHOSPHATE REGULATORY HORMONE
-
批准号:2827285
-
项目类别:
-
资助金额:$12.53万
-
财政年份:1999
-
负责人:SUZANNE M JAN DE BEUR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: